The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1

#1 SAGE Therapeutics Inc (NASDAQ:SAGE)

Number of Hedge Fund Holders (as of September 30): 17
Total Value of Hedge Fund Holdings (as of September 30): $744.21 million
Hedge Fund Holdings as Percent of Float (as of September 30): 61.00%

The sell side is bullish on SAGE Therapeutics Inc (NASDAQ:SAGE) as all seven analysts covering the stock have a ‘Buy’ rating, with a consensus price target of $84.43 per share. The analyst’s price target give SAGE 58% upside from current levels. Hedge funds are bullish too, as 17 funds owned 61% of the float at the end of the third quarter. The total amount that the elite funds own in SAGE has also increased, from $106.4 million at the end of June to $744.21 million at the end of September. Shares are up 45% year-to-date. Jeremy Green’s Redmile Group reported holding 1.14 million shares of SAGE as of the end of the third quarter.

Disclosure:None